Skip to main content

Most new moms get the baby blues. But it could be something more serious: postpartum depression

Moments after Jenna Carberg gave birth to her daughter, doctors put the baby on her chest.

“I felt a disconnect right away,” she recalled.

At home, the Orlando, Florida, mom was exhausted and anxious and cried every day. She was eventually diagnosed with postpartum depression — a potentially dangerous condition that can fill a typically joyous time with deep despair.

The mood disorder has been on the rise. A 2024 study in the journal JAMA Network Open found that U.S. rates more than doubled in just over a decade, climbing from 9.4% in 2010 to 19% in 2021, partly due to improved screening and diagnosis.

It can be hard to differentiate the disorder from the much milder and more common “baby blues” brought on by plummeting hormone levels. But recognizing and treating postpartum depression is crucial, said OB-GYN Dr. Tiffany Moore Simas at the University of Massachusetts Chan Medical School.

Moms who go untreated may have problems bonding with and caring for their babies. And they’re at increased risk of suicide.

“A healthy you will ultimately be important for a healthy baby,” Moore Simas said.

___

EDITOR’S NOTE: This story includes discussion of suicide. If you or someone you know needs help, the national suicide and crisis lifeline in the U.S. is available by calling or texting 988.

___

How to tell if postpartum sadness is more than baby blues

Baby blues affects about 8 in 10 new moms, striking shortly after delivery.

“Moms will feel kind of more emotional than normal,” said Dr. Jennifer Payne, an expert in reproductive psychiatry at the University of Virginia.

But the crying jags and feelings of sadness aren’t severe enough to interfere with normal life. Moms should still be able to care for themselves and their babies.

Screening tools can help discern if the problem is more serious. A commonly used 10-item questionnaire, often given at a postpartum checkup, asks how often a mom has experienced feelings such as sadness, panic or worry. A high score points toward the need for further evaluation.

Experts say there’s no single cause of postpartum depression. Genetics, physical changes and emotional issues may contribute to it.

“We’re pretty sure that having a case of the baby blues doesn’t increase your risk of postpartum depression,” Payne said. “But it does seem that both conditions can develop in the same person.”

Signs of postpartum depression to watch out for

If sadness lingers for more than two weeks, that’s one sign.

Others include intense feelings of despair, anxiety, loss of interest, feelings of guilt and worthlessness, low energy and decreased concentration and appetite. Moms may worry constantly about their babies, be unable to sleep, or stop showering for days.

They “feel negatively and badly about themselves. They’ll feel that they’re a bad mother. They might not feel attached to the baby very much,” Payne said.

They may even have thoughts of harming themselves.

Carberg, who gave birth to her daughter in 2016, had such thoughts a couple of times — once while driving with her daughter. She went to a psychiatric facility for a few days and did better for a while.

But she later had a severe breakdown. She sent text messages to her husband, Chris, saying she was sorry, then turned her phone off. Chris desperately tried to reach her, worried she’d hurt herself.

“She luckily went to the hospital ER,” he said.

Postpartum depression can be treated effectively

Ultimately, finding the right medication was the key to Jenna Carberg’s recovery.

“I felt like myself again,” she said after taking the stimulant Vyvanse.

Other medications include antidepressants such as Zoloft or Prozac, or Zurzuvae, the first pill approved for postpartum depression. Talk therapy is another common treatment, and experts also stress the importance of getting enough sleep and support from family and friends.

To help others, the Carbergs started an online information resource — postpartumdepression.org — to provide support and connect patients with professional help.

Doctors advise anyone who thinks they or a loved one may have postpartum depression to reach out to their OB-GYN, primary care doctor or mental health provider.

If necessary, be persistent, said Dr. Kerry Hudson, an OB-GYN at Newport Women’s Health Services in Rhode Island. When she suffered postpartum depression two decades ago, she said, her doctor told her she was just an overstressed medical resident. She finally got help after breaking down in front of colleagues during a presentation.

After therapy and medications, Hudson went on to have a second child. So did the Carbergs. All are doing well.

“When we get people help, I think they can have a good future ahead of them,” Hudson said. “You don’t have to suffer in silence.”

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.

When you have advanced prostate cancer: What living with the disease looks like

(CNN) — “How long do I have to live ?”When I tell a patient he has prostate cancer, this is usually what he asks me first.With early-stage or low-grade prostate cancer, I can offer strong reassurance: Your life expectancy is good — expect a five-year relative survival rate of greater than 99% with treatment. Simply put, most men will not die from low-grade prostate cancer.However, once the cancer has spread outside the prostate to the bones and other organs the answer becomes more difficult. Treatment has changed dramatically over the past decade for advanced prostate cancer. New drugs, better imaging and the earlier use of combined therapies are helping men live longer.In a video released July 15, former President Joe Biden gave an update on his prostate cancer, saying he was receiving treatments that have been going well. In May 2025, Biden officially announced that he had an aggressive form of prostate cancer that had spread to his bones. Since then, based on official updates, he has continued hormone therapy, completed a course of radiation and maintained a public presence.His diagnosis brought renewed attention to prostate cancer screening and treatment. Now, more than a year later, his cancer journey offers an opportunity to examine what has changed in the treatment of advanced prostate cancer — and the hope these offer men living with the disease.I recently saw a patient who was diagnosed three years ago with cancer that had already spread to multiple areas in his bones. Since then, he has taken cruises, traveled with his family and spent weekends babysitting his grandchildren.He gets tired and cannot garden the way he once did. But he is still alive and considers every day a blessing. His experience, and what we see with Biden, shows what living with metastatic prostate cancer can look like today.Understanding survival ratesIf they haven’t asked their doctor already, many patients go online and find five-year survival rates, but every number they may find online comes with a huge asterisk.The American Cancer Society reports five-year relative survival of greater than 99% when prostate cancer is found in or near the prostate. The figure drops to 38% when it has reached distant parts of the body.But that number is based on large groups of men treated years ago. It does not fully reflect the impact of newer treatments — or account for an individual man’s age, overall health and response to therapy.Survival statistics describe groups of patients but do not predict what will happen to one person. That is why the 38% figure cannot tell us how long Biden — or any individual patient — will live. These patients’ outlook depends on details of their cancer and how they are responding to treatments.It’s treated more aggressively nowA man diagnosed with metastatic prostate cancer a decade ago and a man diagnosed today would not receive the same treatment. The thinking now is to use our best treatments early instead of holding back.For years, doctors began with hormone therapy — usually injections that lower testosterone — and saved other treatments until the cancer stopped responding.Today, those injections are often combined from the start with a newer hormone-blocking drug and/or chemotherapy. These combinations have helped men live longer and are one of the biggest shifts of the past decade.What Biden’s diagnosis told usThere are three details about Biden’s cancer that help doctors like me understand how aggressive it is and how to manage it effectively. Official statements highlighted that his cancer had a Gleason score of 9. The cancer had spread to his bones, and it was labeled as hormone-sensitive.The Gleason score is assigned after a pathologist examines biopsy samples. Scores typically range from 6 to 10, with higher numbers indicating more aggressive cancer. A score of 9 falls into the most aggressive category. However, the score alone cannot tell us whether the cancer has spread outside the prostate.When prostate cancer spreads, the most common destination is the bones — particularly the spine, pelvis and ribs. It can also reach organs such as the lungs or liver. Once it has reached distant parts of the body, it is generally not curable, but treatment can put a brake on it for years.Prostate cancer can also be hormone-sensitive or hormone-resistant. Because it typically relies on testosterone to grow, lowering the hormone or blocking its effects can help control the cancer. Hormone-sensitive means it still responds to these treatments.Over time, most advanced or metastatic prostate cancers find ways to grow despite low testosterone levels, which mean they are now hormone-resistant. Lowering testosterone alone is no longer enough to control the cancer, so doctors have to turn to additional therapies.Knowing if the cancer has spreadThe most sensitive imaging test available today is a PSMA PET scan. It uses a radioactive tracer that seeks out a protein found on the surface of prostate cancer cells. Areas containing cancer may appear as bright spots, helping identify where the cancer has spread. The American Urological Association supports using this imaging test to determine whether high-risk prostate cancer has spread and to help establish its stage.A traditional bone scan, used for decades, highlights areas where bone is reacting to injury or disease. It remains an alternative imaging option, but PSMA PET is increasingly replacing its use.What areas light up and where matter when deciding on treatments. A single spot in the spine and cancer that has spread to the liver are both called stage 4, but they are not the same disease and may not be treated the same way.Doctors also consider how much cancer has spread. We label it as “low-volume” disease when the cancer has reached a limited number of areas. High volume is when the spread is more widespread or has reached other organs such as the liver or lungs.Both require treatment that works throughout the body. Treatment for metastatic disease generally includes therapy that works throughout the body. For men with low-volume disease, adding radiation to the prostate may also help them live longer.Biden has completed a course of radiation, but his team has not disclosed what area was treated or enough detail to determine whether his cancer would be considered low- or high-volume.Treatment has become more preciseBeyond starting more treatments earlier, doctors can increasingly tailor therapy to the biology of an individual man’s cancer. We can now test both the tumor and a patient’s own DNA for mutations that help guide treatment.Roughly 1 in 10 men with metastatic prostate cancer carries an inherited mutation affecting the body’s ability to repair DNA. The best known are BRCA1 and BRCA2, the same genes linked to some breast and ovarian cancers.Certain mutations found in the tumor or inherited DNA may make targeted drugs called PARP inhibitors an option. If a mutation is inherited, it also gives family members information they can act on through genetic counseling, testing and earlier screening.Another advance is radioligand therapy. If a scan shows that cancer cells carry a protein called PSMA, doctors can attach radiation to a molecule that seeks out that protein. Delivered through an IV, it targets cancer cells throughout the body. This approach was expanded last year to more men whose cancer had become hormone resistant.Living longer can come with costsEvery treatment can cause side effects. With hormone therapy, one of the first is often hot flashes, similar to what women experience during menopause. These are not dangerous, but they can affect a man’s quality of life.Fatigue is also common. Testosterone helps maintain muscle, so lowering it can reduce strength and energy. Regular walking and resistance training can help preserve muscle and reduce fatigue.The side effect almost no one talks about is loss of sex drive or low libido. At diagnosis, most men are thinking about staying alive, not their libido. But months later, it often matters. It is worth discussing with your care team and your partner rather than assuming it is simply the price of treatment.The side effect I worry about most is weaker bones. Low testosterone reduces bone density, while cancer deposits can weaken the bone’s structure. Follow-up care should include exercise, a bone-density scan, and ensuring adequate levels of calcium and vitamin D. For men with hormone-resistant cancer that has spread to bone, bone-protecting drugs can reduce the risk of fractures and other complications.New or worsening back pain, especially with leg weakness, numbness or trouble controlling the bladder or bowels? These could mean the cancer is pressing on the spinal cord. It is a true medical emergency that requires immediate attention.Cancer care requires a team approachIdeally, several doctors work together to coordinate a patient’s care. The urologist is often the starting point. A medical oncologist manages treatments that work throughout the body, while a radiation oncologist targets specific areas, whether that is the prostate itself or a painful bone lesion. The primary care doctor helps protect the patient’s heart and bones and looks after the person’s overall health.A man’s age, other medical conditions, ability to tolerate side effects and goals for treatment all shape treatment plans. Two men with nearly identical test results may be offered — or choose — different paths based on their health and priorities.Good communication among doctors is essential, but gaps can happen. Being your own advocate means knowing who is on your care team, asking questions and understanding your options.I also recommend bringing someone you trust to important visits for support and to take notes and help you remember what was discussed.More treatments, better testing offer hopeFor men worried about prostate cancer, talk with your health care provider about the benefits and risks of PSA testing. Black men and those with a strong family history should begin that conversation in their 40s. New urinary symptoms are often not cancer, but they still deserve attention, as does blood in the urine or semen, unexplained weight loss and/or persistent back or bone pain.For men living with advanced prostate cancer, there is reason for hope. There are more treatments and better testing than there were a decade ago, and good care pays attention to how a man feels, not just to what his scans show.The-CNN-Wire™ & © 2026 Cable News Network, Inc., a Warner Bros. Discovery Company. All rights reserved.
Read Next Story